NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Misha Miroslav BackonjaC102/106 Study Group

Abstract

To assess the efficacy, tolerability, and safety of NGX-4010, a high-concentration capsaicin dermal patch (capsaicin 640 microg/cm(2), 8%) in patients with postherpetic neuralgia (PHN). Patients were randomized to receive NGX-4010 or control patch in a 4-week, double-blind study. This was followed by an open-label extension phase (up to 48 weeks total) where patients could receive up to three additional treatments no sooner than 12 weeks after initial treatment. The primary efficacy variable was mean change from baseline in mean morning and evening numerical pain rating scale (NPRS) scores. During days 8-28 after the double-blind treatment, NGX-4010 patients had a mean change in NPRS scores from baseline of -32.7% compared with -4.4% for control patients (P = 0.003). Mean NPRS scores decreased from baseline during week 1 in both treatment groups, remained relatively stable through week 12 in NXG-4010 patients, but returned to near baseline during weeks 2-4 in controls. Mean change in NPRS scores from baseline during weeks 2-12 was -33.8% for NGX-4010 and +4.9% for control recipients. A similar decrease in NPRS scores from baseline was maintained with subsequent NGX-4010 treatments, regardless of the number of treatments receive...Continue Reading

References

Aug 1, 1989·Journal of the American Academy of Dermatology·J E BernsteinL E Millikan
Mar 1, 1994·Pain·Sandra E Ward, Debra Gordon
Nov 23, 2000·The New England Journal of Medicine·C P Watson
Jun 19, 2001·Pain·M C Rowbotham, K L Petersen
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert H Dworkin, Kenneth E Schmader
Apr 5, 2003·BMJ : British Medical Journal·Robert W Johnson, Robert H Dworkin
Nov 19, 2003·Archives of Neurology·Robert H DworkinSharon M Weinstein
May 12, 2004·Neurology·Beth F JungRobert H Dworkin
Jun 10, 2005·The Journal of Pain : Official Journal of the American Pain Society·Gerry OsterPaul D Cleary
Jan 24, 2006·Lancet·Ralf Baron, Gunnar Wasner
Oct 26, 2007·Journal of Pain and Symptom Management·David M SimpsonJames Sampson
Jun 11, 2008·Neurology·David M SimpsonUNKNOWN NGX-4010 C107 Study Group
Jun 12, 2010·Journal of Pain and Symptom Management·David M SimpsonUNKNOWN NGX-4010 C118 Study Group

❮ Previous
Next ❯

Citations

Jun 19, 2013·Current Diabetes Reports·Roy Freeman
Jun 25, 2013·Current Treatment Options in Neurology·Maria A Nagel, Don Gilden
Oct 6, 2012·Drugs & Aging·Srinivas Nalamachu, Patricia Morley-Forster
Jun 10, 2011·Journal of Palliative Medicine·Annie Philip, Rajbala Thakur
Oct 6, 2012·European Neurology·Maija Haanpää, Rolf-Detlef Treede
Dec 5, 2012·Chemistry Central Journal·Monica ButnariuSalomeia Putnoky
Jan 5, 2011·Journal of Pain Research·Avinash K BhandaryGerard A Malanga
Jan 21, 2014·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·S KambizE T Walbeehm
Sep 10, 2011·Postgraduate Medicine·Charles E Argoff
Nov 23, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Gordon A IrvingUNKNOWN NGX-4010 C117 Study Group
May 24, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Magaji G UsmanMohammad Abdul Latif
Jan 30, 2014·Drug Delivery·Khomendra Kumar SarwaVinod Kumar Verma
Feb 11, 2014·Drug Delivery·Khomendra Kumar SarwaBhaskar Mazumder
Mar 8, 2011·Current Medical Research and Opinion·Edward P ArmstrongSissi V Pham
May 29, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Till WagnerAndrea Roth-Daniek
Feb 5, 2013·Mayo Clinic Proceedings·Charles E Argoff
Dec 17, 2015·Drugs·Celeste B Burness, Paul L McCormack
Jun 12, 2010·Journal of Pain and Symptom Management·David M SimpsonUNKNOWN NGX-4010 C118 Study Group
Jun 22, 2012·The Journal of Headache and Pain·Jennifer SayanlarSait Ashina
Dec 3, 2013·Pain Practice : the Official Journal of World Institute of Pain·Kai-Uwe KernChris Poole
Oct 30, 2014·The British Journal of Dermatology·C ZeidlerS Ständer
Aug 2, 2013·Journal of Pain & Palliative Care Pharmacotherapy·Tina Khadem, Vanessa Stevens
Mar 24, 2011·Journal of Pain & Palliative Care Pharmacotherapy·Virginia M JonesDavid M Peterson
Aug 14, 2010·Pain·Nanna Brix FinnerupTroels Staehelin Jensen
Nov 21, 2014·Arquivos de neuro-psiquiatria·Pedro SchestatskyWolnei Caumo
Apr 7, 2017·Clinical Nurse Specialist CNS·Joanne O'BrienLinda Elizabeth Nugent
Jan 11, 2014·Therapeutic Advances in Neurological Disorders·John F Peppin, Marco Pappagallo
Sep 3, 2013·Therapeutic Advances in Neurological Disorders·Ganesan BaranidharanArun Bhaskar
Nov 11, 2017·Pain Management·Nebojsa Nick KnezevicKenneth D Candido
Aug 16, 2011·British Journal of Nursing : BJN·Janice EnglandAngela Sell
Sep 20, 2017·British Journal of Pharmacology·Magdalene M Moran, Arpad Szallasi
Feb 1, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria de Lourdes Reyes-EscogidoErika Vazquez-Tzompantzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.